Literature DB >> 12645900

Elevated HGF levels in sera from breast cancer patients detected using a protein microarray ELISA.

Ronald L Woodbury1, Susan M Varnum, Richard C Zangar.   

Abstract

We developed an ELISA in high-density microarray format to detect hepatocyte growth factor (HGF) in human serum. The microassay can detect HGF at sub-pg/mL concentrations in sample volumes of 100 microL or less. The microassay is also quantitative and was used to detect elevated HGF levels in sera from recurrent breast cancer patients. The microarray format provides the potential for high-throughput quantitation of multiple biomarkers in parallel, as demonstrated with a multiplex analysis of five biomarker proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12645900     DOI: 10.1021/pr025506q

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  31 in total

1.  Multiplexed cancer biomarker detection using quartz-based photonic crystal surfaces.

Authors:  Cheng-Sheng Huang; Vikram Chaudhery; Anusha Pokhriyal; Sherine George; James Polans; Meng Lu; Ruimin Tan; Richard C Zangar; Brian T Cunningham
Journal:  Anal Chem       Date:  2011-12-29       Impact factor: 6.986

2.  Macrophage responses to silica nanoparticles are highly conserved across particle sizes.

Authors:  Katrina M Waters; Lisa M Masiello; Richard C Zangar; Barbara J Tarasevich; Norman J Karin; Ryan D Quesenberry; Somnath Bandyopadhyay; Justin G Teeguarden; Joel G Pounds; Brian D Thrall
Journal:  Toxicol Sci       Date:  2008-12-10       Impact factor: 4.849

3.  Employing two distinct photonic crystal resonances to improve fluorescence enhancement.

Authors:  Patrick C Mathias; Hsin-Yu Wu; Brian T Cunningham
Journal:  Appl Phys Lett       Date:  2009-07-17       Impact factor: 3.791

4.  Plasmonic substrates for multiplexed protein microarrays with femtomolar sensitivity and broad dynamic range.

Authors:  Scott M Tabakman; Lana Lau; Joshua T Robinson; Jordan Price; Sarah P Sherlock; Hailiang Wang; Bo Zhang; Zhuo Chen; Stephanie Tangsombatvisit; Justin A Jarrell; Paul J Utz; Hongjie Dai
Journal:  Nat Commun       Date:  2011-09-13       Impact factor: 14.919

5.  Susceptibility to quantum dot induced lung inflammation differs widely among the Collaborative Cross founder mouse strains.

Authors:  David K Scoville; Collin C White; Dianne Botta; Lisa A McConnachie; Megan E Zadworny; Stefanie C Schmuck; Xiaoge Hu; Xiaohu Gao; Jianbo Yu; Russell L Dills; Lianne Sheppard; Martha A Delaney; William C Griffith; Richard P Beyer; Richard C Zangar; Joel G Pounds; Elaine M Faustman; Terrance J Kavanagh
Journal:  Toxicol Appl Pharmacol       Date:  2015-10-21       Impact factor: 4.219

Review 6.  Photonic crystal enhanced fluorescence for early breast cancer biomarker detection.

Authors:  Brian T Cunningham; Richard C Zangar
Journal:  J Biophotonics       Date:  2012-06-27       Impact factor: 3.207

7.  Protein analytical assays for diagnosing, monitoring, and choosing treatment for cancer patients.

Authors:  Alicia D Powers; Sean P Palecek
Journal:  J Healthc Eng       Date:  2012-12       Impact factor: 2.682

8.  Photonic Crystal Surfaces as a General Purpose Platform for Label-Free and Fluorescent Assays.

Authors:  Brian T Cunningham
Journal:  JALA Charlottesv Va       Date:  2010-04-01

9.  Methodology and applications of disease biomarker identification in human serum.

Authors:  Ziad J Sahab; Suzan M Semaan; Qing-Xiang Amy Sang
Journal:  Biomark Insights       Date:  2007-02-14

10.  Protein modifications as potential biomarkers in breast cancer.

Authors:  Hongjun Jin; Richard C Zangar
Journal:  Biomark Insights       Date:  2009-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.